Effectiveness and Safety of Combination of Nebivolol and Zofenopril in Hypertensive patIents Versus Each Monotherapy

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 283 participants.

Also called NCT05257148

  • Study
  • In this atlas

Overview

Design
Interventional study; non-randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 283 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT05257148
  • EudraCT 2020-002340-23
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
Italy (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT05257148. Non-randomized; no masking; primary purpose treatment. Start 2021-05-26 (actual); primary completion 2021-12-22 (actual). Results posted on 2024-09-20.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Effectiveness and Safety of Combination of Nebivolol and Zofenopril in Hypertensive patIents Versus Each Monotherapy
Acronym
Masaccio
Condition
Hypertension
Intervention (Drug)
Zofenopril 30 mg
Intervention (Drug)
Nebivolol 5 mg
Intervention (Drug)
Zofenopril 30 mg + Nebivolol 5 mg
Lead sponsor
Menarini International Operations Luxembourg SA (class: industry)

Record details

Record id
cardio:ct-nct05257148
Content hash
4220b53e1bc270b467bb7dd7edb886e86caefe0308137bbe1ef5c10f8c21d567